Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alcoholic hepatitis.

David A Sass1, Obaid S Shaikh

  • 1Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Kaufmann Medical Building, Suite 916, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA.

Clinics in Liver Disease
|September 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis C and risk of tuberculosis amongst United States veterans: a national cohort study.

Lancet regional health. Americas·2026
Same author

A Rare Case of Fluid Overload-Associated Large B-Cell Lymphoma in a Patient With Hepatitis C Cirrhosis.

ACG case reports journal·2026
Same author

Hepatocellular Carcinoma Among Patients With Metabolic Dysfunction Associated Steatotic Liver Disease.

Gastro hep advances·2025
Same author

Hepatitis Delta Coinfection Rates and All-Cause Mortality Among Hepatitis B-Infected Veterans in the USA.

Journal of viral hepatitis·2024
Same author

COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and Vaccinated.

The Journal of infectious diseases·2024
Same author

The impact of COVID-19 on the clinical course and outcome of patients with cirrhosis: An observational study.

Health science reports·2024
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Alcoholic hepatitis, a severe liver injury from excessive alcohol, presents with jaundice and fatigue. Its severity, assessed by the Maddrey Discriminant Function, predicts high short-term mortality.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Alcoholic hepatitis is a critical liver condition linked to heavy alcohol consumption.
  • It presents with symptoms like jaundice, fatigue, and malaise.
  • High morbidity and mortality rates are associated with this hepatic injury.

Purpose of the Study:

  • To summarize the epidemiology, pathogenesis, pathology, and clinical features of alcoholic hepatitis.
  • To emphasize prognostic scoring systems for outcome prediction.
  • To review current therapeutic options for alcoholic hepatitis.

Main Methods:

  • Review of existing literature on alcoholic hepatitis.
  • Analysis of clinical presentation and diagnostic criteria.
  • Evaluation of prognostic scoring systems, including the Maddrey Discriminant Function.

Related Experiment Videos

  • Assessment of treatment strategies.

    • Main Results:

    • Alcoholic hepatitis is characterized by significant liver damage and inflammation.
    • Severity assessment using tools like the Maddrey Discriminant Function is crucial for predicting patient outcomes.
    • Short-term mortality can be substantial, particularly in severe cases.

    Conclusions:

    • Early identification and accurate severity assessment are vital for managing alcoholic hepatitis.
    • Prognostic scoring systems guide treatment decisions and patient management.
    • Further research into effective therapeutic options is warranted to improve patient survival rates.